|
Volumn 107, Issue 2, 1994, Pages 543-553
|
Aprotinin for coronary bypass operations: Efficacy, safety, and influence on early saphenous vein graft patency: A multicenter, randomized, double-blind, placebo-controlled study
a a b c d e f f e f c d c |
Author keywords
[No Author keywords available]
|
Indexed keywords
APROTININ;
PLACEBO;
ARTICLE;
BLEEDING;
BLOOD TRANSFUSION;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY BYPASS GRAFT;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG SAFETY;
HEART INFARCTION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SAPHENOUS VEIN GRAFT;
SURGICAL MORTALITY;
APROTININ;
BLOOD LOSS, SURGICAL;
BLOOD TRANSFUSION;
BLOOD VOLUME;
CORONARY ARTERY BYPASS;
DOUBLE-BLIND METHOD;
GRAFT OCCLUSION, VASCULAR;
HEMOSTASIS, SURGICAL;
HUMANS;
MYOCARDIAL INFARCTION;
POSTOPERATIVE COMPLICATIONS;
REOPERATION;
TOMOGRAPHY, X-RAY COMPUTED;
|
EID: 0028314146
PISSN: 00225223
EISSN: None
Source Type: Journal
DOI: 10.1016/S0022-5223(94)70101-6 Document Type: Article |
Times cited : (198)
|
References (27)
|